Fludarabine phosphate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Fludarabine Phosphate.
Product ID | 45963-609_13fec225-ce1e-4855-936d-7166a066ba9a |
NDC | 45963-609 |
Product Type | Human Prescription Drug |
Proprietary Name | Fludarabine phosphate |
Generic Name | Fludarabine Phosphate |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-01-05 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078610 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | FLUDARABINE PHOSPHATE |
Active Ingredient Strength | 50 mg/2mL |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-01-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA078610 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-05 |
Ingredient | Strength |
---|---|
FLUDARABINE PHOSPHATE | 50 mg/2mL |
SPL SET ID: | 3adca34b-4f65-4e21-8058-3c01fc7fc9bb |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
16729-131 | FLUDARABINE PHOSPHATE | FLUDARABINE |
24201-237 | fludarabine phosphate | fludarabine phosphate |
25021-237 | fludarabine phosphate | fludarabine phosphate |
25021-242 | Fludarabine Phosphate | Fludarabine Phosphate |
45963-609 | Fludarabine phosphate | Fludarabine phosphate |
45963-621 | Fludarabine phosphate | Fludarabine phosphate |
59923-604 | Fludarabine Phosphate | Fludarabine Phosphate |
61703-344 | Fludarabine Phosphate | FLUDARABINE PHOSPHATE |
66758-046 | Fludarabine Phosphate | Fludarabine Phosphate |
63323-192 | Fludarabine | FLUDARABINE PHOSPHATE |